Egy Dronate 2 Tablets

Egy Dronate 2 Tablets

Description:

Egy Dronate 2 Tablets is a prescription oral medicine combining alendronate and vitamin D3 (cholecalciferol), formulated specifically for bone and joint health. It is used in the management and treatment of osteoporosis in postmenopausal women, helping to increase bone mineral density and reduce the risk of fractures, especially in the hip and spine. Alendronate is a bisphosphonate that slows bone resorption, while vitamin D3 supports calcium absorption and proper bone mineralization. This product is intended for adult use under medical supervision as part of a comprehensive osteoporosis treatment and prevention plan.

Indications:

• Treatment of osteoporosis in postmenopausal women.
• Reduction of the risk of vertebral (spine) fractures in patients with established osteoporosis.
• Reduction of the risk of hip fractures in high‑risk postmenopausal women.
• Support of bone mass increase and improvement of bone strength.
• Adjunct to adequate calcium and vitamin D intake in patients with low bone mineral density, as directed by a physician.

Active Ingredients / Key Components:

• Alendronate (as alendronate sodium) – exact strength per tablet not specified in available data.
• Vitamin D3 (cholecalciferol) – exact strength per tablet not specified in available data.
• Note: Precise concentrations (mg or iu) of alendronate and vitamin D3 , please check the product leaflet or the manufacturer’s official website. Please refer to the product pack or patient leaflet for exact dosage strengths.

Dosage & Administration / How to Use:

• Use only as prescribed by your physician and according to the dosing schedule they determine.
• Typically taken orally as a tablet with a full glass of plain water (not mineral water, juice, coffee, or tea).
• Take on an empty stomach, at least 30 minutes before the first food, drink, or other medication of the day, unless your doctor advises otherwise.
• Swallow the tablet whole; do not chew or suck to reduce the risk of mouth, throat, or esophageal irritation.
• After taking the tablet, remain in an upright position (sitting or standing) for at least 30 minutes and do not lie down until after your first food of the day.
• Do not take at bedtime or before rising for the day.
• If you miss a dose, follow your doctor’s instructions; do not double the dose to make up for a missed tablet.
• Duration of treatment and follow‑up (including bone density monitoring) should be determined by your healthcare provider.

Clinical Benefits:

• Helps increase bone mass and bone mineral density in postmenopausal women with osteoporosis.
• Reduces the incidence of vertebral compression fractures and hip fractures when used as directed.
• Inhibits osteoclast‑mediated bone resorption through the action of alendronate, helping to slow bone loss.
• Provides vitamin D3 to support optimal calcium absorption and healthy bone mineralization.
• Supports long‑term bone strength and skeletal health as part of a comprehensive osteoporosis management plan.

Warnings & Contraindications:

• Contraindicated in patients with hypersensitivity to alendronate, vitamin D3, or any excipients in the formulation.
• Contraindicated in patients with abnormalities of the esophagus that delay esophageal emptying (such as stricture or achalasia) or in those who cannot stand or sit upright for at least 30 minutes.
• Use with caution in patients with hypocalcemia; low calcium levels must be corrected before starting therapy.
• Use with caution in patients with severe renal impairment; dose adjustment or alternative therapy may be required as per physician judgment.
• Stop using alendronate and cholecalciferol and contact your doctor immediately if you experience chest pain, difficulty or pain when swallowing, pain or burning under the ribs or in the back, new or worsening heartburn, severe joint, bone, or muscle pain, new or unusual pain in your thigh or hip, or jaw pain, numbness, or swelling.
• Tell your dentist and doctor that you are taking alendronate before any dental procedures; rare cases of osteonecrosis of the jaw have been reported with bisphosphonates.
• Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding; this product is primarily indicated for postmenopausal women and is generally not recommended during pregnancy or lactation.
• Use cautiously if you have gastrointestinal disorders such as Barrett’s esophagus, gastritis, duodenitis, ulcers, or severe reflux disease.
• Ensure adequate intake of calcium and vitamin D from diet or supplements as advised by your healthcare provider.
• Consult your doctor before use if you are taking other medications (e.g., calcium supplements, antacids, corticosteroids, anticonvulsants, or other osteoporosis treatments).
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include mild gastrointestinal symptoms such as abdominal pain, dyspepsia (indigestion), nausea, constipation, diarrhea, or flatulence.
• Other possible effects include headache, musculoskeletal pain (bone, joint, or muscle pain), or mild fatigue.
• Serious side effects (seek immediate medical attention) may include chest pain, difficulty or pain when swallowing, severe or persistent heartburn, pain or burning under the ribs or in the back, severe bone, joint, or muscle pain, new or unusual pain in the thigh or hip (possible atypical femoral fracture), or jaw pain, numbness, or swelling (possible osteonecrosis of the jaw).
• Allergic reactions such as rash, itching, swelling of the face, lips, tongue, or throat, or difficulty breathing require urgent medical care.
• This is not a complete list of side effects. Always read the patient information leaflet and consult your doctor or pharmacist if you experience any unusual symptoms.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the package insert, and protect from excessive heat and moisture.

Specifications:

• Product form: tablets.
• Pack size: 2 tablets per pack.
• Intended use: prescription medicine for osteoporosis management in adults, especially postmenopausal women.
• Route of administration: oral.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.